Ph II Study of Azacitidine in Myelofibrosis

NCT00569660 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Myelofibrosis

Interventions

DRUG: Azacitidine

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]